4
Changes in Ownership
HALOZYME THERAPEUTICS, INC. Filed Acc 0001179110-21-009952
President and CEO sold 50,000 shares at an average $39.82 ($1,990,768)
- President and CEO acquired 50,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Torley Helen · President and CEO
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-11-08 | Exercise or conversion : show line 1 in the form | +50,000 | $14.66 | $733,000 | 587,160 | D |
| 2021-11-08 | Sale : show line 2 in the form | −37,775 | $39.62 | $1,496,646 | 549,385 | D |
| 2021-11-08 | Sale : show line 3 in the form | −12,225 | $40.42 | $494,122 | 537,160 | D |
| Open-market sales · 50,000 sh · avg $39.82 · $1,990,768 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|
| 2021-11-08 | Exercise or conversion : show line 4 in the form Option to Purchase Common Stock | −50,000 | $14.66 | $733,000 | $14.66 | 2024-01-06 | 50,000 | 150,000 | D |
Loading xslF345X03/edgar.xml…